Libera Bio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface, transmembrane or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. << Fraud Alert for Potential Candidates >> At Libera Bio, your personal information and online safety are our top priorities. • Candidates should apply exclusively through our official webpage at https://www.liberabio.com/contact/ or rrhh@liberabio.com. • If we collaborate with recruiters, they will always represent well-established and reputable firms. • We will NEVER ask for payments, financial account details, or sensitive data like social security numbers during the recruitment process. Stay safe
| Website | http://www.liberabio.com |
| Employees | 9 (4 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology Research |
| Competitors | Moderna Therapeutics, CureVac, Zymergen, Inc., Regeneron, Roche, Novartis, Sanofi, Amgen, Pfizer, AstraZeneca +37 more (view full list) |
Looking for a particular LiberaBio employee's phone or email?
Desirée Teijeiro Osorio is the CEO of LiberaBio.
4 people are employed at LiberaBio.
LiberaBio is based in Santiago de Compostela, Galicia.